ResearcherHarbin Medical UniversityActive in the last 2 years

Shuang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-7136-1485; OpenAlex author ID A5107950763. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Engineered exosomes: a promising approach for overcoming challenges in pancreatic cancer therapy. Last author DOI 10.1186/s12951-025-03697-0 ↗
Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformatics. Co-author DOI 10.1038/s41598-024-68385-9 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yin Xu · 1 shared paper, 2025 · strength 0.30
- Paper Engineered exosomes: a promising approach for overcoming challenges in pancreatic cancer therapy. DOI 10.1186/s12951-025-03697-0 ↗
Mo Sha · 1 shared paper, 2025 · strength 0.30
- Paper Engineered exosomes: a promising approach for overcoming challenges in pancreatic cancer therapy. DOI 10.1186/s12951-025-03697-0 ↗
Qihang Yuan · 1 shared paper, 2024 · strength 0.22
- Paper Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformat… DOI 10.1038/s41598-024-68385-9 ↗
Bing Qi · 1 shared paper, 2024 · strength 0.22
- Paper Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformat… DOI 10.1038/s41598-024-68385-9 ↗
Xu Chen · 1 shared paper, 2024 · strength 0.22
- Paper Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformat… DOI 10.1038/s41598-024-68385-9 ↗
Dong Shang · 1 shared paper, 2024 · strength 0.22
- Paper Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformat… DOI 10.1038/s41598-024-68385-9 ↗
Jifeng Liu · 1 shared paper, 2024 · strength 0.22
- Paper Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformat… DOI 10.1038/s41598-024-68385-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.